Aravind Life Sciences' ₹3,500 Crore IPO!
Hyderabad: Aravind Life Sciences, a Hyderabad-based company backed by global investment banking giant Goldman Sachs, is preparing for its Initial Public Offering (IPO). It is reported that the company will soon submit its Draft Red Herring Prospectus (DRHP) to SEBI for approval. The company aims to raise up to ₹3,500 crore through the IPO.
You Might Also Like
-
A mega merger is likely in the global pharmaceutical sector. International pharma giants AstraZen...
-
Hyderabad: Aravind Life Sciences, a Hyderabad-based company backed by global investment banking g...
Leave A Comment
Comments